152 related articles for article (PubMed ID: 35688263)
1. Exosomes deliver lncRNA DARS-AS1 siRNA to inhibit chronic unpredictable mild stress-induced TNBC metastasis.
Liu X; Zhang G; Yu T; He J; Liu J; Chai X; Zhao G; Yin D; Zhang C
Cancer Lett; 2022 Sep; 543():215781. PubMed ID: 35688263
[TBL] [Abstract][Full Text] [Related]
2. LncRNA FAM83H-AS1 promotes triple-negative breast cancer progression by regulating the miR-136-5p/metadherin axis.
Han C; Fu Y; Zeng N; Yin J; Li Q
Aging (Albany NY); 2020 Feb; 12(4):3594-3616. PubMed ID: 32074085
[TBL] [Abstract][Full Text] [Related]
3. CL4-modified exosomes deliver lncRNA DARS-AS1 siRNA to suppress triple-negative breast cancer progression and attenuate doxorubicin resistance by inhibiting autophagy.
Liu X; Zhang G; Yu T; Liu J; Chai X; Yin D; Zhang C
Int J Biol Macromol; 2023 Oct; 250():126147. PubMed ID: 37544559
[TBL] [Abstract][Full Text] [Related]
4. LncRNA HAND2-AS1 suppressed the growth of triple negative breast cancer via reducing secretion of MSCs derived exosomal miR-106a-5p.
Xing L; Tang X; Wu K; Huang X; Yi Y; Huan J
Aging (Albany NY); 2020 Dec; 13(1):424-436. PubMed ID: 33290256
[TBL] [Abstract][Full Text] [Related]
5. LncRNA WEE2-AS1 promotes proliferation and inhibits apoptosis in triple negative breast cancer cells via regulating miR-32-5p/TOB1 axis.
Wang R; Huang Z; Qian C; Wang M; Zheng Y; Jiang R; Yu C
Biochem Biophys Res Commun; 2020 Jun; 526(4):1005-1012. PubMed ID: 32307083
[TBL] [Abstract][Full Text] [Related]
6. POU2F2-mediated upregulation of lncRNA
Li J; Li PT; Wu W; Ding BN; Wen YG; Cai HL; Liu SX; Hong T; Zhang JF; Zhou JD; Qian LY; Du J
Epigenomics; 2024 Feb; 16(4):215-231. PubMed ID: 38318853
[TBL] [Abstract][Full Text] [Related]
7. Long non-coding RNA MIDEAS-AS1 inhibits growth and metastasis of triple-negative breast cancer via transcriptionally activating NCALD.
Luo D; Liang Y; Wang Y; Ye F; Jin Y; Li Y; Han D; Wang Z; Chen B; Zhao W; Wang L; Chen X; Jiang L; Yang Q
Breast Cancer Res; 2023 Sep; 25(1):109. PubMed ID: 37770991
[TBL] [Abstract][Full Text] [Related]
8. LncRNA DARS-AS1 regulates microRNA-129 to promote malignant progression of thyroid cancer.
Zheng W; Tian X; Cai L; Shen YM; Cao QS; Yang JY; Tian GY
Eur Rev Med Pharmacol Sci; 2019 Dec; 23(23):10443-10452. PubMed ID: 31841198
[TBL] [Abstract][Full Text] [Related]
9. Formononetin relieves the facilitating effect of lncRNA AFAP1-AS1-miR-195/miR-545 axis on progression and chemo-resistance of triple-negative breast cancer.
Wu J; Xu W; Ma L; Sheng J; Ye M; Chen H; Zhang Y; Wang B; Liao M; Meng T; Zhou Y; Chen H
Aging (Albany NY); 2021 Jul; 13(14):18191-18222. PubMed ID: 34289449
[TBL] [Abstract][Full Text] [Related]
10. LncRNA DARS-AS1 aggravates the growth and metastasis of hepatocellular carcinoma via regulating the miR-3200-5p-Cytoskeleton associated protein 2 (CKAP2) axis.
Feng Y; Wei G; Zhang L; Zhou H; Wang W; Guo P; Cheng C; Ji L; Cai Q; Feng Y; Tu H
Bioengineered; 2021 Dec; 12(1):8217-8232. PubMed ID: 34596006
[TBL] [Abstract][Full Text] [Related]
11. lncRNA DARS-AS1 Promoted Osteosarcoma Progression through Regulating miR-532-3p/CCR7.
Xue Y; Liu H; Nie G; Ren X
Dis Markers; 2022; 2022():4660217. PubMed ID: 35422889
[TBL] [Abstract][Full Text] [Related]
12. Proliferation-associated long noncoding RNA, TMPO-AS1, is a potential therapeutic target for triple-negative breast cancer.
Mitobe Y; Ikeda K; Sato W; Kodama Y; Naito M; Gotoh N; Miyata K; Kataoka K; Sasaki H; Horie-Inoue K; Inoue S
Cancer Sci; 2020 Jul; 111(7):2440-2450. PubMed ID: 32437068
[TBL] [Abstract][Full Text] [Related]
13. Potentiated lung adenocarcinoma (LUAD) cell growth, migration and invasion by lncRNA DARS-AS1 via miR-188-5p/ KLF12 axis.
Liu Y; Liang L; Ji L; Zhang F; Chen D; Duan S; Shen H; Liang Y; Chen Y
Aging (Albany NY); 2021 Oct; 13(19):23376-23392. PubMed ID: 34644678
[TBL] [Abstract][Full Text] [Related]
14. Long non-coding RNA LRRC75A-AS1 facilitates triple negative breast cancer cell proliferation and invasion via functioning as a ceRNA to modulate BAALC.
Li S; Wu D; Jia H; Zhang Z
Cell Death Dis; 2020 Aug; 11(8):643. PubMed ID: 32811810
[TBL] [Abstract][Full Text] [Related]
15. lncRNA AFAP1-AS1 promotes triple negative breast cancer cell proliferation and invasion via targeting miR-145 to regulate MTH1 expression.
Zhang X; Zhou Y; Mao F; Lin Y; Shen S; Sun Q
Sci Rep; 2020 May; 10(1):7662. PubMed ID: 32376943
[TBL] [Abstract][Full Text] [Related]
16. MiR-526b targets lncRNA SLC16A1-AS1 to suppress cell proliferation in triple-negative breast cancer.
Zhao X; Fu L; Zhai L; Yang X; Gao R
J Biochem Mol Toxicol; 2023 Mar; 37(3):e23247. PubMed ID: 36654514
[TBL] [Abstract][Full Text] [Related]
17. Epigenetic regulation of triple negative breast cancer (TNBC) by TGF-β signaling.
Vishnubalaji R; Alajez NM
Sci Rep; 2021 Jul; 11(1):15410. PubMed ID: 34326372
[TBL] [Abstract][Full Text] [Related]
18. Oncogenic Long Noncoding RNA DARS-AS1 in Childhood Acute Myeloid Leukemia by Binding to microRNA-425.
Dou B; Jiang Z; Chen X; Wang C; Wu J; An J; Sheng G
Technol Cancer Res Treat; 2020; 19():1533033820965580. PubMed ID: 33073700
[TBL] [Abstract][Full Text] [Related]
19. ZEB1 induced-upregulation of long noncoding RNA ZEB1-AS1 facilitates the progression of triple negative breast cancer by binding with ELAVL1 to maintain the stability of ZEB1 mRNA.
Luo N; Zhang K; Li X; Hu Y
J Cell Biochem; 2020 Oct; 121(10):4176-4187. PubMed ID: 31922280
[TBL] [Abstract][Full Text] [Related]
20. LncRNA GATA3-AS1 facilitates tumour progression and immune escape in triple-negative breast cancer through destabilization of GATA3 but stabilization of PD-L1.
Zhang M; Wang N; Song P; Fu Y; Ren Y; Li Z; Wang J
Cell Prolif; 2020 Sep; 53(9):e12855. PubMed ID: 32687248
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
